Zhejiang Cheng Yi Pharmaceutical Co Ltd
603811
Company Profile
Business description
Zhejiang Cheng Yi Pharmaceutical Co Ltd is a pharmaceutical company that produces capsules, injections, tablets, APIs, and pharmaceutical intermediates in China. Its main products include glucosamine hydrochloride raw materials and preparations, torasemide injection and capsules, Gastrodin raw materials, ribavirin and purine raw materials, and so on.
Contact
Lane 988, Shenhong Road
7th Floor, No. 9, Building 20, Fuli Yuedu
Minhang District
Shanghai201100
CHNT: +86 2133283397
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
637
Stocks News & Analysis
stocks
Chart of the Week: The market may be underestimating Amcor’s long term potential
Our latest stock pitch.
stocks
Competitive pressures highlight need to lower costs for big 4 bank
Market reacts positively to results.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,901.30 | 3.20 | -0.04% |
| CAC 40 | 8,232.49 | 8.75 | -0.11% |
| DAX 40 | 24,041.62 | 339.84 | -1.39% |
| Dow JONES (US) | 47,457.22 | 797.60 | -1.65% |
| FTSE 100 | 9,807.68 | 103.74 | -1.05% |
| HKSE | 26,723.92 | 349.11 | -1.29% |
| NASDAQ | 22,870.36 | 536.10 | -2.29% |
| Nikkei 225 | 50,379.29 | 902.54 | -1.76% |
| NZX 50 Index | 13,464.46 | 133.41 | -0.98% |
| S&P 500 | 6,737.49 | 113.43 | -1.66% |
| S&P/ASX 200 | 8,628.80 | 3.20 | 0.04% |
| SSE Composite Index | 4,022.89 | 6.61 | -0.16% |